• JXY, TLR4, and M1 Polarization in CAC

  2026-08-23

  Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting macrophages toward an M1-like state through TLR4-associated signaling. The study integrates pathological assessment, macrophage phenotyping, functional assays, and pharmacological pathway perturbation to connect immune remodeling with reduced tumor burden.

• Ceapin-A7: Mapping ER Stress to Cell Fate

  2026-08-22

  A translational framework for using Ceapin-A7 to separate ATF6α signaling from the PERK–JAK1–STAT3 axis in ER stress-driven pyroptosis research.

• Naturally Occurring Angiotensin Peptides and Spike Binding

  2026-08-22

  A 2025 study found that naturally occurring angiotensin fragments can alter SARS-CoV-2 spike-protein binding to host receptors, with especially strong effects observed for shorter and N-terminally modified peptides. The work connects renin-angiotensin system peptide processing with viral receptor biology while emphasizing that binding changes require validation in infection, physiological, and clinical models.

• QPRT, P2Y11 Signaling, and Breast Cancer Invasion

  2026-08-21

  The reference study identifies QPRT as a regulator of breast cancer cell invasiveness and links its activity to purinergic signaling and myosin light chain phosphorylation. Genetic and pharmacological experiments suggest a QPRT–P2Y11–Rho/ROCK–PLC/MLCK axis that may help explain how altered NAD+ metabolism is connected to cytoskeletal remodeling.

• Moxidectin–Polyene Synergy in Oral Candidiasis

  2026-08-20

  Ye and colleagues show that moxidectin potentiates amphotericin B and Nystatin by increasing Candida albicans ergosterol, the membrane target of polyenes. Genetic, transcriptomic, biochemical, and mouse-model data support a target-amplification strategy, while the study also defines important limits for translating this approach beyond oral candidiasis.

• MALAT1–miR-125b/STAT3 Axis in Sepsis

  2026-08-20

  The reference study identifies a MALAT1–miR-125b–STAT3 regulatory axis that increases procalcitonin expression in sepsis-associated models. By combining patient samples, LPS-stimulated U937 cells, localization studies, and interaction assays, it provides a mechanistic framework for interpreting PCT regulation while highlighting the need for validation beyond an in vitro system.

• Reserpine (N1867): Practical Lab Workflow

  2026-08-19

  Reserpine (SKU N1867) provides a characterized research compound for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide covers preparation, storage, QC, and troubleshooting; the material is for research use only and is not intended for diagnostic, therapeutic, or clinical applications.

• O-GlcNAcylation Regulates Galectin-3 in XEN Differentiation

  2026-08-19

  Gatie and colleagues show that extraembryonic endoderm differentiation is accompanied by reduced global O-GlcNAcylation and a redistribution of galectin-3 toward extracellular secretion. Their experiments distinguish correlation from causation: pharmacologically maintaining O-GlcNAc levels did not prevent embryonic stem cell differentiation, suggesting that this modification is associated with, but is not sufficient to control, XEN lineage commitment.

• Anlotinib hydrochloride in Angiogenesis Assays

  2026-08-18

  Learn how to apply Anlotinib hydrochloride as a multi-target tyrosine kinase inhibitor in endothelial migration, tube formation, and pathway-validation workflows. This practical guide connects receptor-level potency with assay design, controls, troubleshooting, and translational cancer research use cases.

• Dasatinib Monohydrate: Assay Reliability Guide

  2026-08-18

  This scenario-based guide explains how Dasatinib Monohydrate (SKU B5954) can support reproducible viability, proliferation, cytotoxicity, and kinase-inhibition experiments. It connects formulation, dosing design, NET biology, resistance modeling, and practical supplier-selection criteria to evidence from product data and published CML research.

• Stattic: Practical STAT3 Inhibitor Workflows

  2026-08-17

  Stattic enables time-controlled interrogation of STAT3 signaling in tumor-cell assays, with practical applications spanning pathway validation, apoptosis induction, and radiation-response studies. This workflow connects STAT3 inhibition with microbiome-associated cancer mechanisms while emphasizing dose design, assay controls, and troubleshooting.

• Anlotinib Hydrochloride: An Assay Design Guide

  2026-08-17

  Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor with a distinctive assay profile spanning VEGFR2, PDGFRβ, FGFR1, angiogenesis, and ERK signaling. This guide translates its pharmacology and a rare-tumor case report into practical decisions for cancer research workflows.

• Digoxin: Mechanism-to-Assay Research Guide

  2026-08-16

  Digoxin is a Na+/K+ ATPase pump inhibitor that links ion transport to cardiac contractility modulation and cell-context-dependent chikungunya research. This guide provides a mechanistic framework for choosing endpoints, concentrations, controls, and translational interpretations.

• Lopinavir (ABT-378): From HIV to MERS-CoV

  2026-08-15

  A translational analysis of Lopinavir (ABT-378), connecting its engineered HIV protease potency and serum resilience with the phenotypic evidence that identified it as a low-micromolar MERS-CoV replication inhibitor. The article outlines assay strategy, resistance-focused validation, exposure considerations, and the limits of cross-pathogen repurposing.

• Penicillin G Sodium: Assay Workflows

  2026-08-14

  Build more reproducible antibacterial and infection-model assays with Penicillin G Sodium by combining stability-aware preparation, schedule-controlled exposure, and orthogonal bacterial and host readouts. A reference-study-inspired workflow also helps distinguish true antimicrobial effects from contamination control, cell injury, and resistance-related failure.

8102 records 1/541 page Next 12345 下5页 Last page